Upgrade to SI Premium - Free Trial

Bernstein: 'Still like Biohaven Pharmaceutical Holding (BHVN) Stock but No Longer a Top Pick'; PT Lowered

March 4, 2025 6:52 AM
Bernstein SocGen Group analyst William Pickering lowered the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $57.00 (from $73.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles